111 related articles for article (PubMed ID: 11254673)
1. LP-BM5 virus-infected mice produce activating autoantibodies to the AMPA receptor.
Koustova E; Sei Y; Fossom L; Wei ML; Usherwood PN; Keele NB; Rogawski MA; Basile AS
J Clin Invest; 2001 Mar; 107(6):737-44. PubMed ID: 11254673
[TBL] [Abstract][Full Text] [Related]
2. Glutamate receptor antibodies directed against AMPA receptors subunit 3 peptide B (GluR3B) can be produced in DBA/2J mice, lower seizure threshold and induce abnormal behavior.
Ganor Y; Goldberg-Stern H; Cohen R; Teichberg V; Levite M
Psychoneuroendocrinology; 2014 Apr; 42():106-17. PubMed ID: 24636507
[TBL] [Abstract][Full Text] [Related]
3. IgG isolated from LP-BM5 infected mouse brain activates ionotropic glutamate receptors.
Basile AS; Koustova E; Ioan P; Rizzoli S; Rogawski MA; Usherwood PN
Neurobiol Dis; 2001 Dec; 8(6):1069-81. PubMed ID: 11741402
[TBL] [Abstract][Full Text] [Related]
4. Ecotropic murine leukemia viruses and exogenous mouse mammary tumor viruses are not essential for pristane-induced lupus.
Akaogi J; Nacionales DC; Kuroda Y; Reeves WH; Satoh M
Arthritis Rheum; 2003 Oct; 48(10):2990-2. PubMed ID: 14558108
[No Abstract] [Full Text] [Related]
5. Regional decreases [corrected] in AMPA receptor density in mice infected with the LP-BM5 murine leukemia virus.
Kustova Y; Espey MG; Sei Y; Basile AS
Neuroreport; 1997 Mar; 8(5):1243-7. PubMed ID: 9175122
[TBL] [Abstract][Full Text] [Related]
6. Glutathione Depletion Is Linked with Th2 Polarization in Mice with a Retrovirus-Induced Immunodeficiency Syndrome, Murine AIDS: Role of Proglutathione Molecules as Immunotherapeutics.
Brundu S; Palma L; Picceri GG; Ligi D; Orlandi C; Galluzzi L; Chiarantini L; Casabianca A; Schiavano GF; Santi M; Mannello F; Green K; Smietana M; Magnani M; Fraternale A
J Virol; 2016 Aug; 90(16):7118-7130. PubMed ID: 27226373
[TBL] [Abstract][Full Text] [Related]
7. The absence of IDO upregulates type I IFN production, resulting in suppression of viral replication in the retrovirus-infected mouse.
Hoshi M; Saito K; Hara A; Taguchi A; Ohtaki H; Tanaka R; Fujigaki H; Osawa Y; Takemura M; Matsunami H; Ito H; Seishima M
J Immunol; 2010 Sep; 185(6):3305-12. PubMed ID: 20693424
[TBL] [Abstract][Full Text] [Related]
8. Antibodies to glutamate receptor subtype 3 (GluR3) are found in some patients suffering from epilepsy as the main disease, but not in patients whose epilepsy accompanies antiphospholipid syndrome or Sneddon's syndrome.
Ganor Y; Goldberg-Stern H; Blank M; Shoenfeld Y; Dobrynina LA; Kalashnikova L; Levite M
Autoimmunity; 2005 Sep; 38(6):417-24. PubMed ID: 16278146
[TBL] [Abstract][Full Text] [Related]
9. Changes in neuronal protein expression in LP-BM5-infected mice.
Takahashi K; Saito K; Masuda J; Fujigaki S; Takemura M; Ito H; Seishima M
Neurosci Lett; 2007 Jul; 422(2):114-8. PubMed ID: 17602838
[TBL] [Abstract][Full Text] [Related]
10. Glutamate receptor antibodies directed against AMPA receptors subunit 3 peptide B (GluR3B) associate with some cognitive/psychiatric/behavioral abnormalities in epilepsy patients.
Goldberg-Stern H; Ganor Y; Cohen R; Pollak L; Teichberg V; Levite M
Psychoneuroendocrinology; 2014 Feb; 40():221-31. PubMed ID: 24485494
[TBL] [Abstract][Full Text] [Related]
11. Strain-related variations of AMPA receptor modulation by calcium-dependent mechanisms in the hippocampus: contribution of lipoxygenase metabolites of arachidonic acid.
Ménard C; Valastro B; Martel MA; Martinoli MG; Massicotte G
Brain Res; 2004 Jun; 1010(1-2):134-43. PubMed ID: 15126126
[TBL] [Abstract][Full Text] [Related]
12. Differential co-expression of AMPA receptor subunits in substance P receptor-containing neurons of basal forebrain regions of C57/BL mice.
Zhang JP; Wei LC; Cao R; Chen LW
Neurochem Int; 2006 Aug; 49(3):319-26. PubMed ID: 16580093
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune epilepsy: some epilepsy patients harbor autoantibodies to glutamate receptors and dsDNA on both sides of the blood-brain barrier, which may kill neurons and decrease in brain fluids after hemispherotomy.
Ganor Y; Goldberg-Stern H; Amrom D; Lerman-Sagie T; Teichberg VI; Pelled D; Futerman AH; Zeev BB; Freilinger M; Verheulpen D; Van Bogaert P; Levite M
Clin Dev Immunol; 2004; 11(3-4):241-52. PubMed ID: 15559370
[TBL] [Abstract][Full Text] [Related]
14. Effect of non-H-2-linked genes on anti-virus immune responses and long-term survival in mice persistently infected with E-55+ murine leukemia virus.
Avidan N; Tumas-Brundage KM; Sieck TG; Prystowsky MB; Blank KJ
Virology; 1995 Aug; 211(2):507-15. PubMed ID: 7645254
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of AMPA receptor subunits in substance P receptor-containing neurons of the caudate-putamen of rats.
Hu HJ; Chen LW; Yung KK; Chan YS
Neurosci Res; 2004 Jul; 49(3):281-8. PubMed ID: 15196776
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies to the glutamate receptor kill neurons via activation of the receptor ion channel.
Levite M; Fleidervish IA; Schwarz A; Pelled D; Futerman AH
J Autoimmun; 1999 Aug; 13(1):61-72. PubMed ID: 10441169
[TBL] [Abstract][Full Text] [Related]
17. Novel alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) receptor antagonists of 2,3-benzodiazepine type: chemical synthesis, in vitro characterization, and in vivo prevention of acute neurodegeneration.
Elger B; Huth A; Neuhaus R; Ottow E; Schneider H; Seilheimer B; Turski L
J Med Chem; 2005 Jul; 48(14):4618-27. PubMed ID: 15999999
[TBL] [Abstract][Full Text] [Related]
18. Evidence for a continued requirement for CD40/CD40 ligand (CD154) interactions in the progression of LP-BM5 retrovirus-induced murine AIDS.
Green KA; Noelle RJ; Green WR
Virology; 1998 Feb; 241(2):260-8. PubMed ID: 9499800
[TBL] [Abstract][Full Text] [Related]
19. Functional characterization of YM928, a novel moncompetitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonist.
Ohno K; Tsutsumi R; Matsumoto N; Yamashita H; Amada Y; Shishikura J; Yatsugi HI; Okada M; Sakamoto S; Yamaguchi T
J Pharmacol Exp Ther; 2003 Jul; 306(1):66-72. PubMed ID: 12660313
[TBL] [Abstract][Full Text] [Related]
20. Differences in the immune response during the acute phase of E-55+ murine leukemia virus infection in progressor BALB and long term nonprogressor C57BL mice.
Panoutsakopoulou V; Little CS; Sieck TG; Blankenhorn EP; Blank KJ
J Immunol; 1998 Jul; 161(1):17-26. PubMed ID: 9647202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
